Pharmacists in Newington, Connecticut


45 Pharmacists found in Newington
female pharmacist

Nancy Merrill Klatt, R PH


Pharmacist
555 Willard Ave, Va Medical Center, Newington, CT 06111
860-667-6750    

female pharmacist

Natasha Froonjian Hartford, PHARMD


Pharmacist
206 Kitts Ln, Newington, CT 06111
860-594-7123     844-411-6589

male pharmacist

Paolo Amenta, PHARMD


Pharmacist
2280 Berlin Turnpike, Newington, CT 06111
860-333-9032    



male pharmacist

Phong Kieu


Pharmacist
2286 Berlin Tpke, Newington, CT 06111
860-343-5220     860-343-5230

male pharmacist

Ramy Mahrous


Pharmacist
3265 Berlin Tpke, Newington, CT 06111
860-616-0023    

female pharmacist

Mrs. Sarah Jordan, PHARM.D.


Pharmacist
555 Willard Ave, Newington, CT 06111
860-667-6750    

male pharmacist

Dr. Seth Thomas Cioffi, PHARM.D.


Pharmacist - Pharmacotherapy
555 Willard Ave, Pharmacy Department, Newington, CT 06111
860-666-6951    

female pharmacist

Sharon Toth


Pharmacist
40 Cedar St, Newington, CT 06111
860-666-4079     860-666-8818

female pharmacist

Stephanie Adamidis, PHARMD


Pharmacist
2920 Berlin Tpke, Newington, CT 06111
860-667-0461    

female pharmacist

Susan M Coste, RPH


Pharmacist
229 Walsh Avenue, Newington, CT 06111
860-665-8004    

female pharmacist

Temilola Odesina


Pharmacist
555 Willard Ave, Newington, CT 06111
860-667-6888    

male pharmacist

Thaddeus John Golebiewski Iii, RPH


Pharmacist
1181 Main St, Newington, CT 06111
860-667-1888    

male pharmacist

Thomas Linskey, PHARMD, RPH


Pharmacist
2920 Berlin Tpke, Newington, CT 06111
860-667-0461    


Type of Pharmacists:
Psychiatric Pharmacist: A licensed pharmacist who has demonstrated specialized knowledge and skill in optimizing care of patients with psychiatric illness by assessing and monitoring patients, recognizing drug-induced problems, and recommending appropriate treatment plans.
Oncology Pharmacist: A licensed pharmacist who has demonstrated specialized knowledge and skill in developing, recommending, implementing, monitoring, and modifying pharmacotherapeutic plans to optimize outcomes in patients with malignant diseases.